The effect of topical adrenergic and anticholinergic agents on the choroidal thickness of young healthy adults

作者：Sander Beata P^*; Collins Michael J; Read Scott A

来源：Experimental Eye Research, 2014, 128: 181-189.

DOI：10.1016/j.exer.2014.10.003

• Choroid
• Autonomic nervous system
• Choroidal thickness
• Parasympatholytic
• Sympathomimetic

The human choroid is capable of rapidly changing its thickness in response to a variety of stimuli. However little is known about the role of the autonomic nervous system in the regulation of the thickness of the choroid. Therefore, we investigated the effect of topical parasympatholytic and sympathomimetic agents upon the choroidal thickness and ocular biometrics of young healthy adult subjects. Fourteen subjects (mean age 27.9 +/- 4 years) participated in this randomized, single-masked, placebo-controlled study. Each subject had measurements of choroidal thickness (ChT) and ocular biometrics of their right eye taken before, and then 30 and 60 min following the administration of topical pharmacological agents. Three different drugs: 2% homatropine hydrobromide, 2.5% phenylephrine hydrochloride and a placebo (0.3% hydroxypropyl methylcellulose) were tested in all subjects; each on different days (at the same time of the day) in randomized order. Participants were masked to the pharmacological agent being used at each testing session. The instillation of 2% homatropine resulted in a small but significant increase in subfoveal ChT at 30 and 60 min after drug instillation (mean change 7 +/- 3 mu m and 14 +/- 2 gm respectively; both p %26lt; 0.0001). The parafoveal choroid also exhibited a similar magnitude, significant increase in thickness with time after 2% homatropine (p %26lt; 0.001), with a mean change of 7 +/- 0.3 mu m and 13 +/- 1 mu m (in the region located 0.5 mm from the fovea center), 6 +/- 1 mu m and 12.5 +/- 1 mu m (1 mm from the fovea center) and 6 +/- 2 mu m and 12 +/- 2 mu m (1.5 mm from the fovea center) after 30 and 60 min respectively. Axial length decreased significantly 60 min after homatropine (p %26lt; 0.01). There were also significant changes in lens thickness (LT) and anterior chamber depth (ACD) (p %26lt; 0.05) associated with homatropine instillation. No significant changes in choroidal thickness, or ocular biometrics were found after 2.5% phenylephrine or placebo at any examination points (p %26gt; 0.05). In human subjects, significant increases in subfoveal and parafoveal choroidal thickness occurred after administration of 2% homatropine and this implies an involvement of the parasympathetic system in the control of choroidal thickness in humans.

• 出版日期2014-11